Tag: phd

Senior Bioinformatics Analyst in New York, NY for Weill Cornell Medicine

Details Posted: 09-Feb-24 Location: New York, New York Salary: Open Categories: Academic/Faculty Medical – Clinical Senior Bioinformatics Analyst Title: Senior Bioinformatics Analyst Location: Upper East Side Org Unit: Steven Josefowicz Lab Work Days: Monday-Friday Exemption Status: Exempt Salary Range: $108,600.00 – $126,600.00 *As required under NYC Human Rights Law Int…

Continue Reading Senior Bioinformatics Analyst in New York, NY for Weill Cornell Medicine

Belantamab Mafodotin Tops Daratumumab in Multiple Myeloma

TOPLINE: Belantamab mafodotin plus a combination of bortezomib and dexamethasone improved median progression-free survival (PFS) by 23 months in patients with relapsed or refractory multiple myeloma compared with daratumumab alongside the same combination. METHODOLOGY: Belantamab mafodotin, a first-in-class anti-BCMA monoclonal antibody conjugate, was approved in the US in 2020 for…

Continue Reading Belantamab Mafodotin Tops Daratumumab in Multiple Myeloma

Bristol Myers Squibb hiring Machine Learning/AI Scientist Computational Tissue Imaging Research, Translational Bioinformatics in Cambridge, MA

Working with UsChallenging. Meaningful. Life-changing. Those aren’t words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work…

Continue Reading Bristol Myers Squibb hiring Machine Learning/AI Scientist Computational Tissue Imaging Research, Translational Bioinformatics in Cambridge, MA

jobs – QIIME 2 Forum

About the q2-jobs category 0 664 July 5, 2018 MS/PhD/Postdoc position in the Department of Biomedical Informatics at the University of Arkansas for Medical Sciences 0 166 June 7, 2023 Research Software Engineer for microbiome bioinformatics at ETH Zurich 0 406 June 7, 2023 Microbial Ecology Postdoctoral Researcher at Smithsonian,…

Continue Reading jobs – QIIME 2 Forum

King’s College London hiring Research Associate in Translational Bioinformatics in London, England, United Kingdom

Job DescriptionThis is a Pre-Fellowship for early career researchers wanting to establish a career in MND translational research and become MND research leaders of the future. The postholder will have a leading role in an exciting new project funded by Motor Neurone Disease Association and MND Scotland. The project is…

Continue Reading King’s College London hiring Research Associate in Translational Bioinformatics in London, England, United Kingdom

Professor of Medical Bioinformatics and Statistical Genetics job with Aarhus University (AU)

The Department of Biomedicine at Faculty of Health at Aarhus University invites applications for a position as Professor in the field of Medical Bioinformatics and Statistical Genetics as per 1 July 2024 or as soon as possible thereafter. The position is a time-limited full-time position for 5 years with extension…

Continue Reading Professor of Medical Bioinformatics and Statistical Genetics job with Aarhus University (AU)

rPFS and cPFS May Act as Surrogate OS End Points in Phase 3 mHSPC Clinical Trials

Both radiographic progression-free survival (rPFS) and clinical PFS (cPFS) appear to be valid surrogates for overall survival (OS) in phase 3 clinical trials evaluating testosterone suppression–based treatment strategies for patients with metastatic hormone-sensitive prostate cancer (mHSPC), according to findings from a study that were published in the Journal of Clinical…

Continue Reading rPFS and cPFS May Act as Surrogate OS End Points in Phase 3 mHSPC Clinical Trials

First patients treated with Abbott’s pulsed field ablation offering

Abbott announced this week that more than 30 patients in Australia were treated with the company’s new pulsed field ablation (PFA) system, representing the first time the technology has been used to treat arrhythmias such as atrial fibrillation in a clinical setting. The procedures were performed by Prash Sanders, MBBS,…

Continue Reading First patients treated with Abbott’s pulsed field ablation offering

Path to Safer Genome Engineering: CRISPR Off-Switches?

Using CRISPR, an immune system bacteria use to protect themselves from viruses, scientists have harnessed the power to edit genetic information within cells. In fact, the first CRISPR-based therapeutic was recently approved by the FDA to treat sickle cell disease in December 2023. That therapy is based on a highly…

Continue Reading Path to Safer Genome Engineering: CRISPR Off-Switches?

Postdoc/assistant professor in molecular biology and bioinformatics: Structural variations associated to circular DNA in cancer – University of Copenhagen – job portal

Job Portal Postdoc/assistant professor in molecular biology and bioinformatics: Structural variations associated to circular DNA in cancer Department of Biology, Faculty of Science at University of Copenhagen is offering a position in molecular biology and bioinformatics for a Postdoc/assistant professor for the analysis of extrachromosomal circular DNA in 1 April…

Continue Reading Postdoc/assistant professor in molecular biology and bioinformatics: Structural variations associated to circular DNA in cancer – University of Copenhagen – job portal

r – RStudio loading the wrong file

Closed. This question needs debugging details. It is not currently accepting answers. I’m trying to load an .RData file and a different file appears in the environment pane. My code: load(“C:/Users/lisam/Desktop/PhD/comp3 POPANE/analysis/R/segData/segData_S5/newlist_allfiles_ps_S5.RData”) The name of the file that loads: newlist_allfiles_S5 I’ve also tried using: setwd(“C:/Users/lisam/Desktop/PhD/comp3 POPANE/analysis/R/segData/segData_S5”) load (“newlist_allfiles_ps_S5.RData”) Have also…

Continue Reading r – RStudio loading the wrong file

IPSCs used to study common genetic cause of chILD

Researchers observed many quantifiable differences between diseased cells made from affected children and their gene-edited cells. Researchers from the Center for Regenerative Medicine (CReM) of Boston University and Boston Medical Center and collaborators at Washington University School of Medicine have shown how they can now study the most common genetic…

Continue Reading IPSCs used to study common genetic cause of chILD

Postdoc assessing the hazards of nano and micro plastics for humans

Category Research / Academic Location Wageningen Do you want to use your passion to study the possible risks of exposure to nano and microplastics for human health as a Post Doctoral researcher? Are you motivated to work in an team of scientists in an ambitious Dutch research program? Do you…

Continue Reading Postdoc assessing the hazards of nano and micro plastics for humans

Senior Bioinformatics Research Scientist – Appcast

We are seeking a talented, highly motivated Senior Bioinformatics Research Scientist to lead our bioinformatics pipeline and develop innovative solutions for analyzing and visualizing omics data related to innate immune signaling projects. The candidate will work both collaboratively and independently on projects within the Kanneganti lab in the Department of…

Continue Reading Senior Bioinformatics Research Scientist – Appcast

Career Associated – International Centre of Insect Physiology and Ecology (icipe)

All jobs > Research > International Centre of Insect Physiology and Ecology (icipe) – Postdoctoral Research Fellow (Bioinformatics) International Centre of Insect Physiology and Ecology (icipe) Get a free C.V. review by sending your C.V. to submitcv@careerassociated.com or click the following link. Submit C.V.! use the subject heading REVIEW. IMPORTANT: Read the…

Continue Reading Career Associated – International Centre of Insect Physiology and Ecology (icipe)

CRISPR off-switches: A path towards safer gen

Using CRISPR, an immune system bacteria use to protect themselves from viruses, scientists have harnessed the power to edit genetic information within cells. In fact, the first CRISPR-based therapeutic was recently approved by the FDA to treat sickle cell disease in December 2023. That therapy is based on a highly…

Continue Reading CRISPR off-switches: A path towards safer gen

Doctoral Researchers in Molecular Medicine and Life Sciences job with UNIVERSITY OF HELSINKI

As part of the Nordic EMBL Partnership for Molecular Medicine, the Institute for Molecular Medicine Finland (FIMM) invites applications for the positions of Doctoral Researchers in Molecular Medicine and Life Sciences We currently have 2-4 openings for doctoral researchers as part of the FIMM-EMBL international PhD programme starting in August 2024. In this interdisciplinary…

Continue Reading Doctoral Researchers in Molecular Medicine and Life Sciences job with UNIVERSITY OF HELSINKI

Memorial Sloan Kettering Cancer Center hiring Bioinformatics Software Engineer III – Chan Lab in New York, NY

 The people of Memorial Sloan Kettering Cancer Center (MSK) are united by a singular mission: ending cancer for life. Our specialized care teams provide personalized, compassionate, expert care to patients of all ages. Informed by basic research done at our Sloan Kettering Institute, scientists across MSK collaborate to conduct innovative…

Continue Reading Memorial Sloan Kettering Cancer Center hiring Bioinformatics Software Engineer III – Chan Lab in New York, NY

10 Kaggle Competitions Every Young Data Scientist Should Check Out

Unlike high school lessons and exams, competitions can offer some much-needed practical experience. Participating in data science competitions not only allows you to hone your coding and analytical skills but also provides hands-on experience in tackling real-world problems. These competitions act as a dynamic playground where you can put your…

Continue Reading 10 Kaggle Competitions Every Young Data Scientist Should Check Out

Post-Doctoral and PhD positions, La Sapienza University, Italy

Post-Doctoral and PhD positions: Join our vibrant team! We are currently hiring for various positions – Curators, Post-Docs, PhD, and Master Students. If you are passionate about Bioinformatics and Computational Biology, with a keen interest in Systems Biology, Network-Based, Multi-omic Integration, and deep learning, we want to hear from you!…

Continue Reading Post-Doctoral and PhD positions, La Sapienza University, Italy

Revolutionizing acne treatment with CRISPR technology

Eligo Bioscience is a gene-editing company focused on addressing diseases driven by the expression of bacterial genes from the microbiome, and in its crosshairs, initially, is moderate to severe acne vulgaris, an inflammatory disease that affects about 3% of the global population. This week, we talk to Xavier Duportet, CEO…

Continue Reading Revolutionizing acne treatment with CRISPR technology

Zoology Jobs – Apply Online at jobs.ac.uk

PhD Alert Created Job Alert Created Your PhD alert has been successfully created for this search. Your job alert has been successfully created for this search. Ok Ok jobs.ac.uk Account Required In order to create multiple alerts, you must create a jobs.ac.uk jobseeker account Create Account Create Account Alert Creation…

Continue Reading Zoology Jobs – Apply Online at jobs.ac.uk

Cost and Benefit: Lisocabtagene Maraleucel is Cost Effective as Second-line Treatment for Lymphoma

Lisocabtagene maraleucel (liso-cel; Breyanzi®; Bristol-Myers Squibb), a CD19-directed genetically modified autologous T-cell immunotherapy, also known as chimeric antigen receptor (CAR) T-cell therapy, is a cost effective second line treatment for relapsed and refractory diffuse large B-cell lymphoma (r/r DLBCL). This conclusion is based on results from a study published in…

Continue Reading Cost and Benefit: Lisocabtagene Maraleucel is Cost Effective as Second-line Treatment for Lymphoma

3D-printed device could end animal trials for pharmaceuticals

It is the first device of its kind, created using a 3D printer to form five compartments that replicate the human heart, lungs, kidney, liver, and brain TBS Report / Innovation 30 December, 2023, 09:15 am Last modified: 30 December, 2023, 09:15 am Currently, thousands of animals are used in…

Continue Reading 3D-printed device could end animal trials for pharmaceuticals

Research Associate – Bioinformatics, Cancer Proteomics & Personalized Medicine Job in Vancouver for UBC

Academic Job Category Faculty Non Bargaining Job Title Research Associate – Bioinformatics, Cancer Proteomics & Personalized Medicine Department Lange Laboratory | Department of Pathology and Laboratory Medicine | Faculty of Medicine (Philipp Lange) Posting End Date January 31, 2024 Note: Applications will be accepted until 11:59 PM on the day…

Continue Reading Research Associate – Bioinformatics, Cancer Proteomics & Personalized Medicine Job in Vancouver for UBC

Team Leader Bioinformatics – Ryvu Therapeutics, Krakow

Team Leader Bioinformatics – Ryvu Therapeutics, Krakow Team Leader Bioinformatics Ryvu Therapeutics Krakow, Poland As Bioinformatics Team Leader you will be responsible for development of this area within Data Science department which includes managing and growing the team, setting and executing short and long term plans, propagating collaboration with other…

Continue Reading Team Leader Bioinformatics – Ryvu Therapeutics, Krakow

30 PhD Positions and 2 Postdoc positions, University of Potsdam

30 PhD Positions and 2 Postdoc positions: The CRC 1644 Projects at the University of Potsdam are offering scholarship positions for individuals with a keen interest in Biology, Bioinformatics, Computer Science, Mathematics, or (Bio)physics. These positions, available in clusters A, B, and Z, provide an excellent opportunity for aspiring scholars…

Continue Reading 30 PhD Positions and 2 Postdoc positions, University of Potsdam

Anavex Life Sciences (AVXL) Announces First Entire Clinical Gene Pathway Data of ANAVEX2-73 from AVATAR Study in Patients with Rett Syndrome

Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and other central nervous system (CNS) diseases, today announced the first entire clinical gene pathway data from the…

Continue Reading Anavex Life Sciences (AVXL) Announces First Entire Clinical Gene Pathway Data of ANAVEX2-73 from AVATAR Study in Patients with Rett Syndrome

Doctoral scholarship holder bioinformatics – Academic Positions

Let’s shape the future – University of Antwerp The University of Antwerp is a dynamic, forward-thinking, European university. We offer an innovative academic education to more than 20000 students, conduct pioneering scientific research and play an important service-providing role in society. We are one of the largest, most international and most innovative…

Continue Reading Doctoral scholarship holder bioinformatics – Academic Positions

SC-282 Shows Promising Results for DLBCL

The molecule SC-2882, developed by Scenic Biotech, has shown promising preclinical results for treating diffuse large B cell lymphoma (DLBCL), according to a recently published press release. Although R-CHOP chemotherapy is an effective treatment for most patients with DLBCL, a significant percentage of patients are resistant to treatment or relapse…

Continue Reading SC-282 Shows Promising Results for DLBCL

Postdoctoral Scientist (f/m/d) in Bioinformatics / Computational Proteomics

The Collaborative Research Centre 1381 “Dynamic organization of cellular protein machineries: From biogenesis and modular assembly to function” is looking for a Postdoctoral Scientist (f/m/d) in Bioinformatics / Computational Proteomics Bewerbungsfrist: 15.01.2024 Veröffentlicht: 19.12.2023 Start-date: At the earliest possible date. Fulltime position Kennziffer: 00003485 Beschreibung The position is embedded in…

Continue Reading Postdoctoral Scientist (f/m/d) in Bioinformatics / Computational Proteomics

Roche PhD Student – Bioinformatics approaches for understanding patient response to immunotherapy (temporary contract)

Roche PhD Student – Bioinformatics approaches for understanding patient response to immunotherapy (temporary contract) The Position In Roche’s Pharmaceutical Research and Early Development organisation (pRED), we are united by our mission to transform science into medicines. We develop transformative therapies for patients in order to tackle some of the world’s…

Continue Reading Roche PhD Student – Bioinformatics approaches for understanding patient response to immunotherapy (temporary contract)

Achievements, accolades highlight past year at VUMC | VUMC Reporter

  Editor’s note — the following is a roundup of the news that made headlines at Vanderbilt University Medical Center in 2023.   Whole-genome sequencing agreement Nashville Biosciences LLC, a wholly owned subsidiary of Vanderbilt University Medical Center, and Illumina Inc., a global leader in DNA sequencing and array-based technologies,…

Continue Reading Achievements, accolades highlight past year at VUMC | VUMC Reporter

Bioinformatics scientist | GENOMINES

Job Description Who we are Genomines is a young biotechnology company based in Paris and Saclay, specialized in sustainable extraction of Nickel from plants. The mission of Genomines is to usher in a new era of sustainable mining by using genetically enhanced plants to extract metals from soil (agromining). Through…

Continue Reading Bioinformatics scientist | GENOMINES

University of North Carolina at Chapel Hill hiring Bioinformatics Data Scientist in North Carolina, United States

Posting InformationPosting Information Department Renaissance Computing Inst-637100 Career Area Information Technology Posting Open Date 09/14/2023 Application Deadline 01/02/2024 Open Until Filled No Position Type Permanent Staff (EHRA NF) Working Title Bioinformatics Data Scientist Appointment Type EHRA Non-Faculty Position Number 20059390, 20061324 Vacancy ID NF0007337 Full Time/Part Time Full-Time Permanent FTE…

Continue Reading University of North Carolina at Chapel Hill hiring Bioinformatics Data Scientist in North Carolina, United States

Data Scientist / Bioinformatician, Biologics R&D Job

Job Description 6000! This is the number of associates in the Novartis Institutes for BioMedical Research (NIBR). This division is the innovation engine of Novartis, focusing on new technologies that have the potential to help produce therapeutic breakthroughs for patients. The Biologics Center (NBC) is accommodated within the Novartis Institutes…

Continue Reading Data Scientist / Bioinformatician, Biologics R&D Job

Postdoc in the field of Integrative Bioinformatics and Biostatistics job with MASARYK UNIVERSITY

Department: RECETOX – Faculty of Science Deadline: 15 Jan 2024 Start date: upon agreement Job type: full-time Job field Science and research Bursar of the Faculty of Science, Masaryk University announces an open competition for the position Postdoc in the field of Integrative Bioinformatics and Biostatistics Workplace: RECETOX, Faculty of Science, Masaryk University in…

Continue Reading Postdoc in the field of Integrative Bioinformatics and Biostatistics job with MASARYK UNIVERSITY

3 futuristic ways ultrasound is revolutionising healthcare

Nobody likes the process of getting vaccinated, particularly young children, some of whom are terrified of needles. But research presented in Sydney earlier this month opens the door to a painless alternative – one whose primary downside might be that it’s actually a bit boring. And that’s just one way…

Continue Reading 3 futuristic ways ultrasound is revolutionising healthcare

American Society for Laser Medicine and Surgery (ASLMS) Hosts its 43rd Annual Conference

The American Society for Laser Medicine and Surgery (ASLMS) is regarded as the top international society for the exchange of information on medical laser and energy-based technologies. 2024 marks the 43rd year of the Annual Conference of the ASLMS. ASLMS 2024 will be held April 11–14, 2024, at the Baltimore Convention…

Continue Reading American Society for Laser Medicine and Surgery (ASLMS) Hosts its 43rd Annual Conference

Research spotlight: Structural analysis and i

Martin Taylor, MD, PhD, a physician investigator in the Department of Pathology at Massachusetts General Hospital and an instructor in Pathology at Harvard Medical School, is the lead corresponding author of a new study in Nature, Structural Analysis and Inhibition of Human LINE-1 ORF2 Protein Reveals Novel Adaptations and Functions….

Continue Reading Research spotlight: Structural analysis and i

Sacramento bee obituaries for today

Sacramento,CA Obituaries. The Dignity Memorial® online obituary search tool gives you access to obituaries from thousands of locations across North America. You can search by first or last name, state and publication date. Once you find the obituary you are looking for, you can get important information about upcoming services,…

Continue Reading Sacramento bee obituaries for today

Case Study Reveals Novel Intragenic Deletion of the FXN Gene in Friedreich Ataxia

Ariadna Padró-Miquel, PhD In a recently published case report study of a 32-year-old man with typical clinical features of Friedreich ataxia (FA), parental sample testing led to the identification of a novel intragenic deletion. Overall, the report raises awareness about the potentially higher prevalence of intragenic deletions and highlights the…

Continue Reading Case Study Reveals Novel Intragenic Deletion of the FXN Gene in Friedreich Ataxia

Diving into PyTorch: A Beginner’s Tale of Contribution | by Weinheimergracia | Dec, 2023

Hey there, fellow code wranglers and AI enthusiasts! I’m Cami, your friendly neighborhood tech explorer, and I’m about to take you on a wild ride through my latest adventure: contributing to PyTorch without being an expert in it. Yes, you read that right! My Unexpected Journey into PyTorch So, I…

Continue Reading Diving into PyTorch: A Beginner’s Tale of Contribution | by Weinheimergracia | Dec, 2023

FDA to Review Omalizumab for Patients With Food Allergies

The Food and Drug Administration (FDA) has accepted for Priority Review the Biologics License Application (BLA) for omalizumab for the reduction of allergic reactions, including anaphylaxis, that may occur with accidental exposure to 1 or more foods in adults and pediatric patients aged 1 year and older with food allergy….

Continue Reading FDA to Review Omalizumab for Patients With Food Allergies

UChicago Medicine experts showcase blood cancer research at 65th ASH Annual Meeting

Faculty and trainees from the University of Chicago Medicine Comprehensive Cancer Center (UCCCC) joined the world’s largest hematology community to discuss the latest updates in blood cancers at the 65th American Society of Hematology (ASH) Annual Meeting and Exposition held December 9-12, 2023 in San Diego and online. At the meeting,…

Continue Reading UChicago Medicine experts showcase blood cancer research at 65th ASH Annual Meeting

The Next Chapter in Genome Editing? Tome Emerges from Stealth with $213M

Rahul Kakkar, MD, Tome Biosciences president and CEO While the CRISPR community celebrates the recent first FDA approval of a CRISPR-Cas9 therapy (Casgevy), new entities are making strides in their efforts to write perhaps the definitive new chapter in programmable genome editing. Last week, Tome Biosciences—a developer of genome editing…

Continue Reading The Next Chapter in Genome Editing? Tome Emerges from Stealth with $213M

ASH 2023: Lymphoma Studies May Inform Practice

Studies presented at the ASH Annual Meeting 2023 provided new insights and updates that may inform the treatment of lymphomas. Results from the phase 3 SYMPATICO trial showed that adding venetoclax to ibrutinib can improve progression-free survival (PFS) in patients with relapsed or refractory mantle cell lymphoma (MCL).1 These results…

Continue Reading ASH 2023: Lymphoma Studies May Inform Practice

Casgevy, sickle cell gene-editing therapy, favored for EU approval

A European Medicines Agency committee has issued a positive opinion on the gene-editing therapy Casgevy (exagamglogene autotemcel) in treating sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT). The Committee for Medicinal Products for Human Use (CHMP) recommendation will be considered by the European Commission in making a final approval decision…

Continue Reading Casgevy, sickle cell gene-editing therapy, favored for EU approval

Research Scientist Position – Genomic Basis of Marine Sponge Symbioses – GEOMAR

Research Scientist Position – Genomic Basis of Marine Sponge Symbioses GEOMAR – Helmholtz Centre for Ocean Research Kiel, Germany Project Description: The Hentschel lab at GEOMAR seeks to elucidate the physiological and metabolic functioning and mechanisms of interaction between marine sponges and their symbiotic microbial consortia. Our research covers fundamental…

Continue Reading Research Scientist Position – Genomic Basis of Marine Sponge Symbioses – GEOMAR

Darzalex Faspro combo of help with multiple myeloma diagnosis, transplant

Adding Darzalex Faspro (daratumumab and hyaluronidase) — a subcutaneous or under-the-skin formulation of Darzalex (daratumumab) — to a standard combination therapy regimen led to significantly better outcomes for people who are newly diagnosed with multiple myeloma and transplant eligible. That’s according to four-year data from the Phase 3 PERSEUS (NCT03710603) clinical…

Continue Reading Darzalex Faspro combo of help with multiple myeloma diagnosis, transplant

Postdoctoral Full time jobs in Norway | PhD, Academia

Broaden your search Refine your search Sign up for job alerts Get new jobs for this search by email Found 6 PhD, Academia jobs Three-year full time Postdoc Research Fellowship in cancer immunology is available…

Continue Reading Postdoctoral Full time jobs in Norway | PhD, Academia

Detecting small- and medium-length copy number variants by whole-genome sequencing

Gains and losses of genetic material can be almost any size: a single base pair or an entire chromosome spanning tens of millions. As genomic analysis technologies have evolved, researchers have separated these often medically relevant variants into bins based on their size and the methods used to detect them….

Continue Reading Detecting small- and medium-length copy number variants by whole-genome sequencing

Improving the diagnosis of infection: a prosp

Scientists from Necker-Enfants Malades Hospital (AP-HP), the Institut Pasteur, Université Paris Cité, Inserm, Université Paris-Est Créteil and the Alfort National Veterinary School, coordinated by Professor Marc Eloit and Dr. Anne Jamet in collaboration with Dr. Jacques Fourgeaud and Beatrice Regnault, studied the role of global genetic characterization of samples (or…

Continue Reading Improving the diagnosis of infection: a prosp

Genetic Mechanisms Driving Predisposition to Childhood Kidney Cancer Uncovered

Wilms tumor, also known as nephroblastoma, is a rare kidney cancer that mainly affects children. The average age of diagnosis of Wilms tumor in children depends upon whether one or both kidneys are affected. If one kidney is affected, unilateral Wilms tumor, the age at diagnosis usually is 42–47 months….

Continue Reading Genetic Mechanisms Driving Predisposition to Childhood Kidney Cancer Uncovered

Allosteric Sites Mapped on Key Cancer Protein

Researchers at the Centre for Genomic Regulation and the Wellcome Sanger Institute have comprehensively identified the allosteric control sites found in the protein KRAS, which is one of the most frequently mutated genes in many types of cancer. The scientists used a technology known as deep mutational scanning to quantify…

Continue Reading Allosteric Sites Mapped on Key Cancer Protein

Clinical Challenges: Using Pola-R-CHP for Diffuse Large B-Cell Lymphoma

Earlier this year, the FDA approved a new frontline option for patients with diffuse large B-cell lymphoma (DLBCL): the antibody-drug conjugate polatuzumab vedotin (Polivy) in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone (pola-R-CHP). Combination chemotherapy involving rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) — and before that, CHOP alone —…

Continue Reading Clinical Challenges: Using Pola-R-CHP for Diffuse Large B-Cell Lymphoma

Programmable Genomic Integration Company Raises Over $200 Million

Tome Biosciences – a programmable genomic integration company – recently announced it has launched to usher in a new era of genomic medicines based on programmable genomic integration (PGI). PGI enables the insertion of any DNA sequence of any size into any programmed genomic location. And the company has raised…

Continue Reading Programmable Genomic Integration Company Raises Over $200 Million

BMS Ends Phase 3 Trial of Nivolumab and Relatlimab in CRC

Colorectal Cancer: © peterschreiber.media – stock.adobe.com Bristol Myers Squibb is ending the phase 3 RELATIVITY-123 trial (NCT05328908) investigating nivolumab (Opdivo) and relatlimab (Opdualag) in patients with previously treated metastatic microsatellite stable (MSS) colorectal cancer (CRC) with disease progression following 1, but no more than 4 lines of therapy, due to…

Continue Reading BMS Ends Phase 3 Trial of Nivolumab and Relatlimab in CRC

FDA Fails to Address DNA Adulteration Concerns

The following article originally appeared on Dr. Robert Malone’s Substack, and is reprinted here verbatim with permission. Robert Malone, MD, MS; Malone Institute December 15, 2023, 2:30 PM EST (Madison VA and Tallahassee FL) The failure of government regulatory authorities to identify and disclose DNA fragment contamination of…

Continue Reading FDA Fails to Address DNA Adulteration Concerns

Exploring How Poxviruses Dismantle Antiviral Responses

Derek Walsh, PhD, professor of Microbiology-Immunology, was senior author of the study published in Nature Communications. Northwestern Medicine investigators led by Derek Walsh, PhD, professor of Microbiology-Immunology, have discovered how poxviruses disarm and evade mitochondrial-driven antiviral responses for their replication in host cells, according to findings published in Nature Communications….

Continue Reading Exploring How Poxviruses Dismantle Antiviral Responses

AI Shows Drug Repurposing Potential

Credit: Yuuji/Getty Images A framework that combines two cutting-edge artificial intelligence technologies is offering a fresh perspective on how pre-existing drugs can be used for other clinical indications. The path from the discovery of a new drug to its time to market is arduous, taking 12 years on average and…

Continue Reading AI Shows Drug Repurposing Potential

Illumina to Divest of Grail after Appeals Court Defeat

Battered by more than three years of opposition from authorities in the United States and Europe—most recently an unfavorable federal appeals court decision on Friday—Illumina said it will divest itself of Grail, the cancer blood test developer it bought for $7.1 billion. Illumina said it will carry out the divestiture…

Continue Reading Illumina to Divest of Grail after Appeals Court Defeat

Study finds revolutionary cancer vaccine simultaneously kills and prevents brain cancer

[Dec. 17, 2023: JJ Shavit, The Brighter Side of News] Dual action cell therapy is engineered to eliminate established tumors and train the immune system to eliminate the primary tumor and prevent cancer recurrence. (Credit: Creative Commons) In a bold effort to rewrite the story of cancer treatment, scientists are…

Continue Reading Study finds revolutionary cancer vaccine simultaneously kills and prevents brain cancer

“Evolution and Genomics”, Professor Anna Olivieri is guest of the new Science in the Valley meeting

“Evolution and Genomics: How DNA Changed Our View of the Past,” this is the title of the meeting organized by the association Science in the valley Thursday, December 21, at 6 pm at the association’s headquarters a. Volta Scientific Secondary School San Giovanni Castle (via Nazario Sauro 23). Topic will…

Continue Reading “Evolution and Genomics”, Professor Anna Olivieri is guest of the new Science in the Valley meeting

Research Associate in Computational Biology

Institution/Company: University of British Columbia Location: Vancouver ,&nbspBritish Columbia &nbspCanada Job Type: Research Associate Degree Level Required: PhD new Apply now Read more here: Source link

Continue Reading Research Associate in Computational Biology

Grant-Funded Researcher (B) CREST 2, School of Computer Science job with UNIVERSITY OF ADELAIDE

(Level B) $107,276 – 126,984 per annum plus an employer contribution of 17% superannuation applies. Fixed term position for 18 months The School of Computer Science offers high quality accredited degrees in computer science, and software engineering, has strong links with industry and a robust research ethos. This role will…

Continue Reading Grant-Funded Researcher (B) CREST 2, School of Computer Science job with UNIVERSITY OF ADELAIDE

Postdoctoral Research Associate in Educational Data Science job with UNIVERSITY OF SYDNEY

Full time, fixed term for 2 years Located at the School of Computer Science, Camperdown Campus Base Salary $105K – $108K p.a., + 17% superannuation About the opportunity Established as the first computer science department in Australia, the School of Computer Science (SCS) is research intensive…

Continue Reading Postdoctoral Research Associate in Educational Data Science job with UNIVERSITY OF SYDNEY

What Makes Lymphoma Turn Lethal?

A study by researchers at Columbia and the Hong Kong University of Science and Technology is helping to clarify how low-grade lymphoma changes as it develops into a more aggressive tumor, which could lead to the development of new treatments. Though often incurable, many low-grade B-cell lymphomas are slow to…

Continue Reading What Makes Lymphoma Turn Lethal?

IT/Informatics Job: Bioinformatics Engineer – Pediatric Oncology/Janeway Lab at Dana-Farber Cancer Institute in 450 Brookline Ave, Boston, MA

Responsible for a wide range of technical tasks involving the creation and use of software for the display and manipulation of biological data.  Provides assistance to faculty and research staff in the collection, management, analysis and interpretation of biological data, with a focus on the analysis of data from genomic,…

Continue Reading IT/Informatics Job: Bioinformatics Engineer – Pediatric Oncology/Janeway Lab at Dana-Farber Cancer Institute in 450 Brookline Ave, Boston, MA

Postdoctoral positions in Sustainability, Genomics, Microbiology, and Bioinformatics/Data Science… job with Technical University of Denmark (DTU)

DTU Biosustain is actively seeking candidates for postdoctoral roles in fields such as sustainability, genomics, microbiology, and bioinformatics/data science. We welcome applications from researchers in these or related fields, especially those focusing on large-scale data integration using advanced technologies (e.g., long-read, single-cell, microscopy, metabolic) for sustainable food and agricultural production….

Continue Reading Postdoctoral positions in Sustainability, Genomics, Microbiology, and Bioinformatics/Data Science… job with Technical University of Denmark (DTU)

Unlocking the human genome: Innovative machin

image:  LoGoFunc identifies harmful (left) and harmless (right) genetic variations in the Vasopressin V2 receptor protein using a structure predicted by AlphaFold2. This helps explain how genetic changes affect proteins. view more  Credit: Stein et al., Genome Medicine New York, NY [December 14, 2023]—In a novel study, researchers from the…

Continue Reading Unlocking the human genome: Innovative machin

PhD position at CiMUS (Santiago de Compostela, Spain)

1 PhD position is available at the Gene Regulatory Control in Disease group at CIMUS/University of Santiago de Compostela, Spain (International Campus of Excellence). Using both experimental and computational approaches, our laboratory aims to deconstruct the mechanistic basis for control of gene expression in developmental and pathological contexts at the…

Continue Reading PhD position at CiMUS (Santiago de Compostela, Spain)

Formononetin | FGFR2 inhibitor | Axon 4067

All All Products Enzymes Receptors Ion Channels Research Areas Oxidoreductases Transferases Lyases Isomerases Ligases Nuclear Receptors Ligand-gated ATP-Sensitive Angiogenesis Apoptosis Cardiovascular Cell Cycle Regulation Cell Signaling & Oncology CNS Diabetes & Metabolism Epigenetics Immunology Miscellaneous Pain & Inflammation Stem Cell Oxidases MAO Cys-loop, cationic Cis-Trans Isomerase CypA DNA Topoisomerase Synthetases…

Continue Reading Formononetin | FGFR2 inhibitor | Axon 4067

abcam hiring Principal Bioinformatics Scientist in Cambridge, England, United Kingdom

Company DescriptionFor over 20 years, Abcam has been providing tools the scientific community needs to enable faster breakthroughs in critical areas like cancer, neurological disorders, infectious diseases, and metabolic disorders. We believe that to continue making progress, we need to work together in new ways. We need your own unique…

Continue Reading abcam hiring Principal Bioinformatics Scientist in Cambridge, England, United Kingdom

Enzymes Can’t Tell Artificial DNA from the Real Thing

The genetic alphabet contains just four letters, referring to the four nucleotides, the biochemical building blocks that comprise all DNA. Scientists have long wondered whether it’s possible to add more letters to this alphabet by creating brand-new nucleotides in the lab, but the utility of this innovation depends on whether…

Continue Reading Enzymes Can’t Tell Artificial DNA from the Real Thing

Computational Biology, Bioinformatics Internship – Summer 2024 at Takeda Pharmaceutical

By clicking the “Apply” button, I understand that my employment application process with Takeda will commence and that the information I provide in my application will be processed in line with Takeda’sPrivacy Noticeand Terms of Use. I further attest that all information I submit in my employment application is true…

Continue Reading Computational Biology, Bioinformatics Internship – Summer 2024 at Takeda Pharmaceutical

Tome Biosciences Raises $213M to Commercialize MIT Developed Genome Editing Tech

Methods of editing the genome are powering the development of new cell and gene therapies for diseases that have been challenging to treat. Companies like Tome Biosciences are part of a wave of startups building commercial platforms that leverage CRISPR/Cas9 and other genome editing technologies.  Earlier this week, Tome raised…

Continue Reading Tome Biosciences Raises $213M to Commercialize MIT Developed Genome Editing Tech

Post-doc in bioinformatics: Host-pathogen Omics data analysis

Mots-Clés Bio-informatic, biology, genomic, transcriptomic, infectiology, parasitology Description OUR RESEARCH Why can’t humans control parasite infections? What occurs in our bodies during an infection? What exactly is the parasite doing? We seek answers to these questions by translating biology into data and modeling them. With the revolution in single-cell technologies…

Continue Reading Post-doc in bioinformatics: Host-pathogen Omics data analysis

Approval of gene therapy ‘transformative’ in SCD

New regulatory decisions in the U.S. and the U.K. have made Casgevy (exagamglogene autotemcel) the first gene-editing therapy to be approved for adults and adolescents with sickle cell disease (SCD) who experience painful vaso-occlusive crises (VOCs). With these recent approvals, the therapy from Vertex Pharmaceuticals and CRISPR Therapeutics also became…

Continue Reading Approval of gene therapy ‘transformative’ in SCD

Biopharma Company Issues New Patent Application; Phase 3 Clinical Trials for Cancer Treatments: RenovoRx (NASDAQ: RNXT)

RenovoRx, Inc. Nasdaq: RNXT NASDAQ: RNXT $RNXT Clinical Sites RenovoTAMP $RNXT Battles Cancer Tumors Direct! RenovoTAMP $RNXT Advancing Cancer Treatments: RenovoRx’s Phase 3 Clinical Trials in Partnership with Imugene RenovoRx, Inc. (NASDAQ:RNXT) LOS ANGELES , CALIFORNIA , UNITED STATES , December 14, 2023 /EINPresswire.com/ — Biopharma Company Issues New Patent…

Continue Reading Biopharma Company Issues New Patent Application; Phase 3 Clinical Trials for Cancer Treatments: RenovoRx (NASDAQ: RNXT)

Capricor Reports Positive DSMB Review of Phase 3 HOPE-3 Interim Results

Capricor Therapeutics recently reported a positive futility analysis of its phase 3 HOPE-3 study (NCT05126758) assessing its investigational agent CAP-1002 in patients with Duchenne muscular dystrophy (DMD). Conducted by the study’s Data Safety Monitoring Board (DSMB), the results of the interim analysis resulted in a favorable recommendation to continue the…

Continue Reading Capricor Reports Positive DSMB Review of Phase 3 HOPE-3 Interim Results

Postdoctoral Research Fellow in Laser Physics and Engineering job with MACQUARIE UNIVERSITY – SYDNEY AUSTRALIA

We are seeking qualified two Postdoctoral Research Fellows to join the School of Engineering with an international reputation for producing high quality research outcomes in Laser Physics and Engineering. The successful candidates will make a significant contribution to the development of high-power pulsed fibre lasers that will be used for…

Continue Reading Postdoctoral Research Fellow in Laser Physics and Engineering job with MACQUARIE UNIVERSITY – SYDNEY AUSTRALIA

Researcher in Bioinformatics job with UNIVERSITY OF SYDNEY

Full-time 12 -24-month fixed-term position Research Fellow (Level A) in the Charles Perkins Centre on the Camperdown Campus Base salary starting from $83, 454 plus 17% superannuation About the opportunity The Imaging and Phenotyping Laboratory is a cross-disciplinary, data-intensive scientific group with the mission to revolutionise…

Continue Reading Researcher in Bioinformatics job with UNIVERSITY OF SYDNEY

University Assistant Predoctoral, Life Sciences job with UNIVERSITY OF VIENNA

50 Faculty of Life Sciences Startdate: 01.01.2024 | Working hours: 30 | Collective bargaining agreement: §48 VwGr. B1 Grundstufe (praedoc) Limited until: 31.12.2026 Reference no.: 1758 Among the many good reasons to want to research and teach at the University of Vienna, there is one in particular, which has convinced around 7,500 academic staff members so far. They see…

Continue Reading University Assistant Predoctoral, Life Sciences job with UNIVERSITY OF VIENNA

Global BioImaging – Scientific Manager “Imaging for All – i4A” job with European Molecular Biology Laboratory (EMBL)

About the team/job The Global BioImaging team at the Euro-BioImaging Bio-Hub hosted by the EMBL is seeking a highly motivated international scientific management and imaging professional to launch and coordinate the new “Imaging 4 All – i4A” project under the Global BioImaging network (www.globalbioimaging.org). Global BioImaging (GBI) is a growing…

Continue Reading Global BioImaging – Scientific Manager “Imaging for All – i4A” job with European Molecular Biology Laboratory (EMBL)

Single Cell Data Scientist at European Molecular Biology Laboratory (EMBL)

About the team/job We are looking for a Bioinformatician to join the Open Targets data team. We are seeking an enthusiastic team member to expand our informatics platforms through the integration of single cell omics data to enhance drug discovery. This role would suit someone with experience in data integration…

Continue Reading Single Cell Data Scientist at European Molecular Biology Laboratory (EMBL)

Zafrens Plans to Advance Multimodal Drug Discovery Platform with $23M Financing

Although he started out in theoretical physics, Swamy Vijayan, PhD, has worked in the biotechnology industry for most of his professional career. His path included a stint at Illumina and the launch of Omniome, a short read sequencing company that was acquired by Pacific Biosciences in 2021. His next gig…

Continue Reading Zafrens Plans to Advance Multimodal Drug Discovery Platform with $23M Financing

Scientist (Postdoc) in the field of Bioinformatics/Artificial Intelligence, Leipzig, Sachsen

The Fraunhofer-Gesellschaft () currently operates 76 institutes and research institutions throughout Germany and is the world’s leading applied research organization. Around employees work with an annual research budget of 2.9 billion euros. Its Fraunhofer Institute for Cell Therapy and Immunology IZI researches and develops special problem solutions at the interfaces…

Continue Reading Scientist (Postdoc) in the field of Bioinformatics/Artificial Intelligence, Leipzig, Sachsen

Clinical Challenges: CAR-T or Bispecifics in Relapsed/Refractory DLBCL

T-cell engaging therapeutic approaches have significantly changed the treatment paradigm for relapsed or refractory diffuse large B-cell lymphoma (DLBCL) in recent years. “They are, by a wide margin, the most impactful new therapies for all B-cell lymphomas, but especially DLBCL, in the last 40 years, if not ever,” said Joshua…

Continue Reading Clinical Challenges: CAR-T or Bispecifics in Relapsed/Refractory DLBCL

Increasing Widespread Accessibility of Molecular Testing for Oncology Research

Advancements in cancer diagnostics and monitoring have revolutionized the way we understand and treat this complex disease. The advent of molecular technologies for analyzing nucleic acids has made it possible to detect, analyze and monitor cancer more precisely and sensitively than ever before. Furthermore, it has made noninvasive liquid biopsy…

Continue Reading Increasing Widespread Accessibility of Molecular Testing for Oncology Research

Research Associate in Bioinformatics and Precision Medicine at Imperial College London

Location: St Mary’s, Paddington and South Kensington Campus Job Summary Applications are invited for the post of Research Associate/Fellow in Bioinformatics and Precision Medicine within the Department of Infectious Disease, Faculty of Medicine. You will lead analysis -omic datasets generated from clinical studies of acute infection to inform disease diagnosis…

Continue Reading Research Associate in Bioinformatics and Precision Medicine at Imperial College London

Verastem Oncology Announces Initiation of a Confirmatory Phase 3 Trial of Avutometinib and Defactinib in Recurrent Low-Grade Serous Ovarian Cancer

BOSTON–(BUSINESS WIRE)– Verastem Oncology (Nasdaq: VSTM) (the “Company”), a biopharmaceutical company committed to advancing new medicines for patients with cancer, announced today that it has initiated its international confirmatory Phase 3 RAMP 301 trial (GOG-3097; ENGOT-ov81/NCRI), evaluating the combination of avutometinib and defactinib versus standard chemotherapy or hormonal therapy for the…

Continue Reading Verastem Oncology Announces Initiation of a Confirmatory Phase 3 Trial of Avutometinib and Defactinib in Recurrent Low-Grade Serous Ovarian Cancer

Bioinformatics Engineer – Lifelancer | Career Page

What you will do Work with other engineers and scientists to build Isos platform, applying AI to biological systems. Design, develop and maintain bioinformatics pipelines for the ingestion, management and analysis of biological datasets, especially -omics, imaging, and clinical data. Perform data analysis and data quality assurance according to best…

Continue Reading Bioinformatics Engineer – Lifelancer | Career Page

The first major set of genetic associations found in long COVID

PrecisionLife’s Dr Sayoni Das, a computational biologist who leads the research and development of bioinformatics pipelines that generate biological insights from PrecisionLife’s core technology and support drug discovery programmes, details a new study. Using combinatorial analysis, genetic variants associated with long COVID have been identified and, furthermore, it has been…

Continue Reading The first major set of genetic associations found in long COVID

Data Science Community & Internal Support Lead

Your role You will provide project leadership and coordination to shape data science-related internal support activities and training programs, spanning programming, consulting in complex data analysis, and specialised courses. Engaging with both the scientific community at EMBL and external representatives, your work will enhance training and consulting offerings across EMBL…

Continue Reading Data Science Community & Internal Support Lead

Postdoc on Gut Microbiome and Metagenome

Your job Are you the enthusiastic scientist with a PhD, who is experienced with metagenomics data and wants to focus on understanding the function of our microbiome? Are you interested in how microbes can improve the health of babies? We at Wageningen University and Research have a vacancy for a…

Continue Reading Postdoc on Gut Microbiome and Metagenome

Measurable Residual Disease-Guided Therapy Promising in CLL

SAN DIEGO — In untreated chronic lymphocytic leukemia (CLL), patients who received ibrutinib plus venetoclax for a duration determined by disease characteristics rather than a fixed schedule had significantly better progression-free and overall survival compared with conventional chemoimmunotherapy, a new phase 3 analysis shows. The targeted therapy combination was also…

Continue Reading Measurable Residual Disease-Guided Therapy Promising in CLL

Biopharma Company Reaches Phase 3 Clinical Trials for Cancer Treatments; 9 Patents Issued; Collaboration with Imugene: RenovoRx (NASDAQ: RNXT)

PRESS RELEASE Published December 12, 2023 Clinical-Stage Biopharma Company Developing Proprietary Targeted Combination Therapies for High Unmet Medical Needs in Oncology.   Trans-Arterial Micro-Perfusion (TAMPTM) Therapy Designed to Directly Target Tumors While Potentially Minimizing Toxicities.  Welcomed Ducreux, M.D., Ph.D., Head of the Gastrointestinal Oncology Unit and Gastrointestinal Oncology Tumor Board at…

Continue Reading Biopharma Company Reaches Phase 3 Clinical Trials for Cancer Treatments; 9 Patents Issued; Collaboration with Imugene: RenovoRx (NASDAQ: RNXT)

Northumbria University Research Fellowship Health & Life Science

–Must See– Northumbria University Research Fellowship Research Fellow in Health and Life Sciences Northumbria University, Newcastle City Campus, United Kingdom ABOUT THE ROLE We are seeking to appoint a highly committed, motivated, and creative scientist to join the Northumbria University bioinformatics research group. The research will develop new data science…

Continue Reading Northumbria University Research Fellowship Health & Life Science

Research Unlocks Prediction Potential for Incurable Cancer Progression

Researchers have come one step closer to answering why, in some patients, a type of lymphoma changes from indolent to aggressive, and in particular they are closer to identifying which patients are at high risk of this change happening. Part of the answer lies in the protein expression in the…

Continue Reading Research Unlocks Prediction Potential for Incurable Cancer Progression